PRO 07 - Gynecologic Tumor Board - Case-Based Discussion of the Molecular and Treatment Approach Updates for the Management of Endometrial, Vulvar and Cervical Cancers
Describe the molecular pathologic features that should be included in pathology report for endometrial, vulvar and cervix cancers.
Be able to discuss how pathologic factors, such as molecular status, influence prognosis and treatment decisions.
Discuss recent clinical trial data for the management of gynecologic cancers and define what patient populations show survival benefits with these new approaches, such as immunotherapy.